Cancer Targeted Therapy Market - Strategy Analysis Report

The global cancer targeted therapy market is experiencing significant growth driven by advancements in genomic profiling and biomarker discovery, preference for precision medicine approaches, and robust pipeline of monoclonal antibodies and small molecule inhibitors. Cancer target therapy encompasses monoclonal antibodies, tyrosine kinase inhibitors, immune checkpoint inhibitors, cancer vaccines, gene therapy, and others.

https://www.businessmarketinsi....ghts.com/reports/can

Cancer Targeted Therapy Market Outlook (2021-2031) by Therapy Type, Indication, End User

Cancer Targeted Therapy Market was valued at US$ 95,120.20 Million in 2024 and is projected to reach US$ 235,680.29 Million by 2031 with a CAGR of 14.0% from 2025 to 2031 segmented into Therapy Type, Indication, End User.